Kite Pharma Inc. Company Profile

21:33 EDT 20th March 2018 | BioPortfolio

Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the development of novel cancer immunotherapeutic products, with focus on engineered autologous T cell therapeutics targeted to different tumor types. Kite is based in Los Angeles, CA. For more information, visit the company’s website at

News Articles [696 Associated News Articles listed on BioPortfolio]

Bis zu 190% mit Kite Pharma: Ist Cellectis der nächste Senkrechtstarter?

Das Feld der führenden CAR-T-Zelltherapie-Spezialisten lichtet sich allmählich. Kite Pharma (AKTIONÄR-Leser konnten bis zu 190 Prozent seit der Erstempfehlung einstreichen) und Juno Therapeutics wu...

#news #biotech Gilead makes bolt-on CAR-T buy after Kite deal

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gilead makes bolt-on CAR-T buy after Kite deal .After its $12 billion buyout ...

Kite, Pfizer enter clinical trial collaboration

Gilead Sciences Inc.'s Kite Pharma Inc. is teaming up with Pfizer Inc. in a trial collaboration to study the safety and efficacy of Kite's Yescarta (axicabtagene ciloleucel) in combination with Pfizer...

Kite in deal to trial Yescarta with utomilumab

Kite Pharma has entered into a clinical trial collaboration to evaluate the safety and efficacy of the…

Kite gets wind in its sails as Gilead boosts cell therapy investment

Three months after Gilead Sciences bought fellow Californian biotech Kite Pharma, the HCV specialist…

Kite and Sangamo Therapeutics in Oncology Pact

US-based Kite Pharma, part of Gilead Sciences since October 2017, is collaborating with Sangamo Therapeutics to develop next-generation engineered cell therapies to treat cancer.

Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal

Kite Pharma wasn’t expecting a regulatory decision for its non-Hodgkin lymphoma treatment until November, but this week, the company got the FDA’s O.K. The approval of axicabtagene ciloleucel (Yes...

Kite, Pfizer partner to develop CAR-T/utomilumab combination for blood cancers

Kite Pharma, a Gilead Sciences-acquired firm, will partner with Pfizer to develop a combo regimen to treat certain hematologi -More- 

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [28 Associated PubMed Articles listed on BioPortfolio]

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

My Kite Will Fly: Improving Communication and Understanding in Young Children When a Mother Is Diagnosed with Life-Threatening Gynecological Cancer.

The My Kite Will Fly (MKWF) research program is built on the well-documented need for effective clinical communication tools and therapeutic interventions where a child's mother is diagnosed with life...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Moving pharma contracting into the era of accountability.

Clinical Trials [80 Associated Clinical Trials listed on BioPortfolio]

A Study Evaluating the Safety and Efficacy of KITE-585 in Subjects With Relapsed/Refractory Multiple Myeloma

To evaluate the safety and tolerability of KITE-585, an autologous engineered CAR T-cell product targeting a protein commonly found on myeloma cells called BCMA. Patients will be given a 3...

A Study Evaluating the Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Subjects With Advanced Cancers

Participants who are HLA-DPB1*04:01 positive and whose tumors are MAGE-A3/A6 positive may be eligible for this study. If eligible, white blood cells are collected by apheresis and genetica...

The Pharmacokinetics, Safety, and Ease of Use of a Portable Metered-Dose Cannabis Inhaler

Growing evidence supports the use of inhaled cannabis for neuropathic pain; the lack of standard inhaled dosing holds a major obstacle in cannabis becoming a pharmacological treatment for ...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

Companies [738 Associated Companies listed on BioPortfolio]

Kite Pharma Inc.

Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the development of novel cancer immunotherapeutic products, with focus on engineered autol...

Kite Pharma, Inc.

Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the design and development of cutting-edge immunotherapeutic products to treat different c...

Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. was founded in 2015 and is focused on developing novel protein‐based immunotherapies using its proprietary variant immunoglobulin domain (vIgD) p...

Red Kite Technology Limited

Red Kite Technology specialises in the supply and validation of custom software, instrumentation, automation and control systems for the following:- Process control and automation Data acquisition ...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

More Information about "Kite Pharma Inc." on BioPortfolio

We have published hundreds of Kite Pharma Inc. news stories on BioPortfolio along with dozens of Kite Pharma Inc. Clinical Trials and PubMed Articles about Kite Pharma Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kite Pharma Inc. Companies in our database. You can also find out about relevant Kite Pharma Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record